Braveheart Investment Group plc (LON:BRH – Get Free Report)’s share price was up 14.3% during trading on Thursday . The stock traded as high as GBX 4 ($0.05) and last traded at GBX 4 ($0.05). Approximately 405,503 shares were traded during trading, an increase of 283% from the average daily volume of 105,741 shares. The stock had previously closed at GBX 3.50 ($0.04).
Braveheart Investment Group Trading Up 14.3 %
The company has a fifty day simple moving average of GBX 3.78 and a two-hundred day simple moving average of GBX 4.41. The company has a market capitalization of £2.55 million, a P/E ratio of -31.82 and a beta of -0.34. The company has a debt-to-equity ratio of 0.74, a current ratio of 17.75 and a quick ratio of 18.07.
Insider Activity at Braveheart Investment Group
In other news, insider Trevor Brown bought 2,595,701 shares of the stock in a transaction that occurred on Thursday, November 7th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £103,828.04 ($131,627.84). 31.49% of the stock is owned by company insiders.
About Braveheart Investment Group
Braveheart Investment Group plc is a private equity and venture capital firm specializing in loan, mezzanine, seed/startup, early venture, late stage, emerging growth, turnaround, distress situations, buyout in growth capital companies. It prefers to invest in materials, industrials, commercial and professional services, consumer discretionary, consumer services, consumer staples, health care, financials, information technology, communication services, media, engineering services, sporting goods and services, biotechnology, internet software, digital, and entertainment.
See Also
- Five stocks we like better than Braveheart Investment Group
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Invest in 5G? How to Invest in 5G Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Buy P&G Now, Before It Sets A New All-Time High
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Braveheart Investment Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braveheart Investment Group and related companies with MarketBeat.com's FREE daily email newsletter.